Risteys ·

Coding

Definition

OMOP Concept ID: 3025296— open in OHDSI Athena.
Part of collection: Carrot (Daucus carota) IgE with 0 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3025296	s-porkkae	u/ml (u/ml)	56	56	7.14%
3025296	s-porkkae	— (—)	38	39	100.00%	Distribution not available

Cohort

Number of people: 92 (83.70% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

No data available for the duration from to last measurement distribution.

Statistics

People with ≥2 records: 3.26%
Median number of measurements per person: 1.0
Median duration from first to last measurement: —

Number of measurements over the years

No data available for the distribution of number of measurements over the years.

Number of measurements per person

Distribution of lab values

Reference range

N people

N records

—

<0.35/KAIKKI

-ALLE0.35

alle0.35/kaikki

Value range per person

No data available for the distribution of value range per person.

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dermatitis and eczema

6.05

19.42

1.0

0.50

1.57

u/ml

0.40

Atopic dermatitis

6.43

16.46

1.0

1.1

0.60

1.71

u/ml

0.37

Urticaria and erythema

8.01

11.04

1.1

1.0

0.84

2.39

u/ml

0.29

Urticaria

9.18

10.96

1.1

1.0

0.80

3.11

u/ml

—

Asthma (mode)

5.16

10.02

1.0

2.10

0.39

u/ml

0.61

Asthma (only as main-diagnosis)

5.15

9.57

1.0

2.32

0.39

u/ml

0.63

Asthma (only as main-diagnosis), excluding more controls

5.08

9.41

1.0

2.32

0.39

u/ml

0.63

ILD medications: prednisolone, methylprednisolone, prednisone

3.89

9.27

1.0

2.00

0.47

u/ml

0.47

Asthma, including avohilmo

3.57

9.11

1.0

1.77

0.29

u/ml

0.65

Oral corticosteroids

3.87

8.84

1.0

2.11

0.49

u/ml

0.48

Asthma

4.66

8.31

1.0

2.22

0.39

u/ml

0.59

Asthma, excluding more controls

4.64

8.25

1.0

2.22

0.39

u/ml

0.59

Vasomotor and allergic rhinitis

4.55

8.11

1.1

1.0

2.85

0.17

u/ml

0.66

Other and unspecified urticaria

10.01

8.01

1.1

1.0

0.43

4.29

u/ml

—

Allergic rhinitis

6.27

7.61

1.1

1.0

2.85

0.12

u/ml

—

D07AA Corticosteroids, weak (group I)

10.00

6.52

1.0

0.49

5.94

u/ml

—

Inflammatory bowel disease treatment related agents

3.06

6.12

1.0

2.23

0.43

u/ml

0.51

Disorders of conjunctiva

3.14

6.11

1.0

2.68

0.18

u/ml

0.79

Conjunctivitis

3.18

6.07

1.0

2.68

0.18

u/ml

0.79

Asthma (diagnoses ohter than nonallergic)

3.09

6.04

1.0

2.09

0.31

u/ml

0.62

Asthma, hospital admissions , main diagnosis only

3.11

5.95

1.0

2.32

0.23

u/ml

0.72

ILD medications

3.02

5.95

1.0

2.23

0.46

u/ml

0.49

Asthma/COPD (KELA code 203)

3.02

5.75

1.0

2.32

0.26

u/ml

0.65

Anxiety disorders, excluding more controls

3.19

5.68

1.0

2.23

0.37

u/ml

0.41

Allergic conjunctivitis

3.30

5.59

1.1

1.0

2.88

0.26

u/ml

0.70

Chronic lower respiratory diseases

2.80

5.58

1.0

2.10

0.26

u/ml

0.69

Dermatitis

4.98

5.53

1.0

0.90

1.87

u/ml

—

Atopic dermatitis, strict definition with reimbursement

5.37

5.49

1.0

0.44

2.11

u/ml

—

Diseases of the skin and subcutaneous tissue

3.63

5.44

1.0

0.20

2.63

u/ml

0.47

First line medication for Crohn's disease

2.92

5.26

1.0

2.33

0.48

u/ml

0.48

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3.24

5.17

1.1

1.0

3.08

0.19

u/ml

0.73

Examination and observation for other reasons

4.03

4.98

1.1

1.0

3.38

0.11

u/ml

—

Neurotic, stress-related and somatoform disorders

2.80

4.74

1.0

2.23

0.43

u/ml

0.39

Anxiety disorders

2.74

4.57

1.0

2.23

0.43

u/ml

0.39

Dentofacial anomalies [including malocclusion]

2.80

4.53

1.0

2.35

0.53

u/ml

0.36

Atopic dermatitis, strict definition

3.87

4.19

1.0

0.44

1.85

u/ml

—

Other and unspecified dermatitis

4.80

4.17

1.0

0.56

2.29

u/ml

—

Tramadol

2.99

3.85

1.0

2.56

0.39

u/ml

0.41

Abnormalities of breathing

2.52

3.62

1.0

1.73

0.74

u/ml

0.25

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.50

3.56

1.0

2.55

0.37

u/ml

0.45

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.33

3.19

1.0

2.40

0.31

u/ml

0.52

Exposure to unspecified factor

2.29

3.06

1.1

1.0

0.78

1.08

u/ml

0.14

Headache

2.56

3.03

1.0

2.86

0.66

u/ml

0.37

Recurrent or chronic depression

3.52

3.02

1.0

4.43

0.36

u/ml

—

Psychiatric diseases

2.34

2.78

1.0

2.43

0.40

u/ml

0.41

Dizziness and giddiness

2.71

2.77

1.0

3.55

0.26

u/ml

—

Migraine

2.50

2.74

1.1

1.0

3.06

0.48

u/ml

—

Bronchitis

2.16

2.74

1.0

2.27

0.39

u/ml

0.53

Mood disorders, excluding more controls

2.31

2.60

1.0

3.29

0.36

u/ml

—

Other joint disorders

2.19

2.58

1.1

1.0

0.70

1.45

u/ml

0.29

Persons encountering health services for specific procedures and health care

2.09

2.51

1.0

0.28

1.16

u/ml

0.53

Other special examinations and investigations of persons without complaint or reported diagnosis

2.86

2.49

1.0

5.19

0.11

u/ml

—

Temporomandibular joint disorders, including avohilmo

2.47

2.45

1.0

3.95

0.25

u/ml

—

Fall on same level involving ice and snow

2.67

2.44

1.0

0.03

1.47

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

2.08

2.29

1.0

1.97

0.74

u/ml

0.31

Opioids

2.06

2.16

1.0

3.34

0.47

u/ml

0.51

Symptoms and signs involving the nervous and musculoskeletal systems

2.62

2.13

1.1

1.0

0.28

1.57

u/ml

—

Other reaction to severe stress, and adjustment disorders

2.78

2.13

1.0

0.16

0.30

u/ml

—

Chronic sinusitis

2.78

2.13

1.0

0.28

0.16

u/ml

—

Diseases of the ear and mastoid process

1.94

2.12

1.0

2.36

0.53

u/ml

0.40

Selective serotonin reuptake inhibitors

2.07

1.99

1.0

3.37

0.45

u/ml

—

Symptoms and signs involving the digestive system and abdomen

2.07

1.98

1.0

2.86

0.50

u/ml

0.40

General symptoms and signs

1.95

1.89

1.0

2.63

0.65

u/ml

0.36

Depression or dysthymia

2.45

1.85

1.0

5.20

0.36

u/ml

—

Carpal tunnel syndrome

2.55

1.84

1.0

0.07

0.38

u/ml

—

Sleep disorders (combined)

1.90

1.80

1.0

2.92

0.39

u/ml

0.44

Mycoses

2.02

1.79

1.0

3.65

0.48

u/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

2.11

1.78

1.1

1.0

3.70

0.33

u/ml

—

Care involving use of rehabilitation procedures

2.25

1.75

1.1

1.0

0.10

1.44

u/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.93

1.74

1.0

2.92

0.36

u/ml

0.45

Insomnia

1.97

1.72

1.1

1.0

3.45

0.37

u/ml

0.56

Mood [affective] disorders

1.89

1.70

1.0

3.29

0.49

u/ml

—

Mood disorders

1.89

1.70

1.0

3.29

0.49

u/ml

—

Other external causes of accidental injury

2.19

1.68

1.0

0.20

2.13

u/ml

—

Anxiety (asthma-related co-morbidities)

2.08

1.67

1.1

1.0

0.77

0.24

u/ml

—

Depression

1.91

1.66

1.0

3.40

0.50

u/ml

—

Chronic diseases of tonsils and adenoids

1.98

1.62

1.0

0.53

0.27

u/ml

0.47

Triptan medication for migraine, single purchase ok

1.92

1.60

1.1

1.0

3.44

0.55

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.92

1.60

1.1

1.0

3.44

0.55

u/ml

—

Certain infectious and parasitic diseases

1.81

1.58

1.0

2.44

0.44

u/ml

0.41

All anxiety disorders

2.01

1.55

1.1

1.0

0.77

0.34

u/ml

—

Pain in throat and chest

2.00

1.54

1.0

0.07

0.52

u/ml

—

Certain infectious and parasitic diseases

2.03

1.53

1.0

3.37

0.18

u/ml

—

Other pulmonary diagnosis

2.23

1.51

1.0

4.30

0.39

u/ml

—

Excluding asthma or asthma-COPD overlap

2.23

1.51

1.0

4.30

0.39

u/ml

—

COPD differential diagnosis

2.23

1.50

1.0

4.30

0.39

u/ml

—

ILD differential diagnosis

2.23

1.50

1.0

4.30

0.39

u/ml

—

Abdominal and pelvic pain

1.90

1.47

1.0

3.15

0.50

u/ml

—

Arthropathies

1.82

1.45

1.1

1.0

0.40

1.45

u/ml

0.46

Dorsopathies

1.78

1.45

1.0

2.95

0.41

u/ml

0.44

Neurological diseases

1.85

1.44

1.1

1.0

3.89

0.51

u/ml

—

Lumbar disc prolapse

2.26

1.43

1.0

5.92

0.42

u/ml

—

Other soft tissue disorders, not elsewhere classified

1.82

1.43

1.1

1.0

3.11

0.60

u/ml

—

Injuries to the wrist and hand

1.78

1.40

1.1

1.0

1.07

1.02

u/ml

—

Constipation

1.94

1.38

1.0

0.14

1.33

u/ml

—

Other intervertebral disc disorders

2.01

1.36

1.0

4.32

0.39

u/ml

—

Dental pulpitis, including avohilmo

1.77

1.36

1.0

3.34

0.47

u/ml

—

Accidents

2.03

1.35

1.0

0.20

2.13

u/ml

—

Lower back pain or/and sciatica

1.75

1.33

1.1

1.0

3.40

0.37

u/ml

0.55

Sleep disorders

1.81

1.32

1.0

3.22

0.37

u/ml

—

Any mental disorder

1.77

1.28

1.0

3.46

0.36

u/ml

—

Dorsalgia

1.75

1.27

1.1

1.0

4.15

0.42

u/ml

—

Acute upper respiratory infections

1.73

1.27

1.0

2.57

0.54

u/ml

0.37

Intestinal infectious diseases

1.68

1.25

1.0

2.52

0.47

u/ml

0.42

Implicit Sepsis

2.09

1.23

1.0

6.14

0.42

u/ml

—

Postpartum care and examination

0.00

1.20

0.0

1.0

—

3.32

—

Pain in limb

1.79

1.20

1.1

1.0

0.09

0.62

u/ml

—

Coronary atherosclerosis

0.00

1.20

0.0

1.0

—

0.43

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.75

1.13

1.0

3.84

0.34

u/ml

—

Diseases of the eye and adnexa

1.79

1.13

1.1

1.0

4.46

0.14

u/ml

—

Inflammatory diseases of female pelvic organs

1.77

1.12

1.1

1.0

0.77

1.19

u/ml

—

Viral infections characterized by skin and mucous membrane lesions

1.69

1.05

1.0

0.46

1.13

u/ml

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.91

1.03

1.0

5.96

0.32

u/ml

—

Episodal and paroxysmal disorders

1.61

1.03

1.1

1.0

2.83

0.62

u/ml

0.37

Diseases of the respiratory system

2.00

1.02

1.0

5.94

0.37

u/ml

—

Cystitis

1.63

1.00

1.0

2.93

0.31

u/ml

0.46

Maternal care for known or suspected fetal abnormality and damage

0.00

0.98

0.0

1.0

—

2.82

—

Falls/tendency to fall

1.59

0.97

1.1

1.0

0.56

1.22

u/ml

—

Cardiovascular diseases

1.65

0.97

1.0

0.19

1.57

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.58

0.91

1.0

3.10

0.46

u/ml

0.47

Other dorsopathies, not elsewhere classified

1.59

0.90

1.0

3.58

0.41

u/ml

—

Fall on same level

1.52

0.89

1.1

1.0

0.35

1.19

u/ml

0.55

Disorders of eyelid, lacrimal system and orbit

1.67

0.89

1.1

1.0

2.00

1.01

u/ml

—

Nerve, nerve root and plexus disorders

1.61

0.87

1.0

3.39

0.50

u/ml

—

1.55

0.87

1.0

2.54

0.43

u/ml

0.39

Antihypertensive medication - note that there are other indications

1.62

0.86

1.1

1.0

0.09

1.65

u/ml

—

Persons encountering health services in other circumstances, wide

1.56

0.85

1.0

3.94

0.31

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.57

0.84

1.0

0.50

1.10

u/ml

—

Other disorders of urethra and urinary system

1.65

0.84

1.1

1.0

6.03

0.33

u/ml

—

Implicit Sepsis

1.71

0.81

1.0

5.12

0.32

u/ml

—

Parasetamol

1.69

0.79

1.0

5.50

0.44

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.58

0.77

1.0

0.56

1.18

u/ml

—

Triptan medication for migraine, min. 3 purchases

1.57

0.73

1.1

1.0

4.34

0.40

u/ml

—

Influenza and pneumonia

1.48

0.72

1.0

0.11

1.23

u/ml

—

Diseases of oesophagus, stomach and duodenum

1.52

0.71

1.0

3.51

0.19

u/ml

—

Pain (limb, back, neck, head abdominally)

1.62

0.70

1.0

6.06

0.63

u/ml

—

1.54

0.70

1.0

0.13

0.44

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.54

0.70

1.0

0.13

0.44

u/ml

—

Hypothyroidism, strict autoimmune

1.55

0.68

1.0

0.56

1.25

u/ml

—

Hypothyroidism, other/unspecified

1.49

0.67

1.0

0.50

1.13

u/ml

—

Tonsillectomy and adenotomy

1.53

0.66

1.0

0.70

1.35

u/ml

—

COPD/asthma/ILD related infections

1.46

0.62

1.0

3.03

0.44

u/ml

—

COPD/asthma related infections

1.46

0.62

1.0

3.03

0.44

u/ml

—

Special screening examination for infectious and parasitic diseases

0.00

0.61

0.0

1.0

—

0.13

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.54

0.61

1.0

0.05

1.37

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.43

0.59

1.0

0.33

1.21

u/ml

0.54

Injuries to the head

1.41

0.59

1.1

1.0

0.85

1.03

u/ml

0.07

Condition for Implicit Sepsis (Organ dysfunction codes)

1.55

0.59

1.0

5.12

0.32

u/ml

—

Haemorrhage in early pregnancy

1.72

0.57

1.0

0.07

2.07

u/ml

—

Low back pain

1.52

0.55

1.1

1.0

1.32

0.44

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

1.47

0.54

1.0

0.21

1.67

u/ml

—

Sleep apnoea, including avohilmo

1.49

0.54

1.0

0.11

1.44

u/ml

—

Autoimmune diseases related-to ILD

1.47

0.53

1.0

0.41

1.00

u/ml

—

Codeine or tramadol medication

1.39

0.51

1.1

1.0

0.68

1.20

u/ml

—

Soft tissue disorders

1.37

0.48

1.1

1.0

3.13

0.59

u/ml

—

Other disorders of ear

1.47

0.48

1.0

0.38

1.32

u/ml

—

Other diseases of upper respiratory tract

1.40

0.47

1.0

3.52

0.27

u/ml

—

Other antidepressants

1.39

0.42

1.0

4.76

0.45

u/ml

—

Myocardial infarction, without ST-elevation

0.00

0.41

0.0

1.0

—

0.13

—

Postpartum haemorrhage due to anatomy

0.00

0.41

0.0

1.0

—

0.30

—

Fracture of rib(s), sternum and thoracic spine

0.00

0.41

0.0

1.0

—

0.14

—

Other diseases of blood and blood-forming organs, wide

0.00

0.41

0.0

1.0

—

3.72

—

Ventral hernia

0.00

0.41

0.0

1.0

—

0.13

—

Heart failure and coronary heart disease

0.00

0.41

0.0

1.0

—

0.11

—

L04AA Selective immunosuppressants

0.00

0.40

0.0

1.0

—

3.37

—

Non-ischemic cardiomyopathy

0.00

0.40

0.0

1.0

—

0.09

—

Disorders of the thyroid gland

1.34

0.40

1.0

0.50

1.10

u/ml

—

Neoplasms

1.30

0.33

1.1

1.0

5.03

0.60

u/ml

—

Chronic apical periodontitis

1.26

0.29

1.0

3.74

0.35

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

1.25

0.27

1.0

0.13

1.07

u/ml

—

All pneumoniae

1.25

0.26

1.0

0.13

1.07

u/ml

—

Other diseases of urinary system

1.23

0.23

1.0

4.38

0.31

u/ml

—

Ovarian dysfunction

0.00

0.21

0.0

1.0

—

5.96

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.0

—

5.92

—

Infections of genitourinary tract in pregnancy

0.00

0.21

0.0

1.0

—

5.91

—

Assault

0.00

0.21

0.0

1.0

—

6.14

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.21

0.0

1.0

—

6.14

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.0

—

6.14

—

Schizophrenia

0.00

0.21

0.0

1.0

—

6.14

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.21

0.0

1.0

—

6.14

—

Sulfonylureas

0.00

0.21

0.0

1.0

—

0.04

—

Puerperal sepsis

0.00

0.21

0.0

1.0

—

0.06

—

Azathioprine

0.00

0.21

0.0

1.0

—

0.13

—

ILD medications: azathioprine

0.00

0.21

0.0

1.0

—

0.13

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

0.21

0.0

1.0

—

0.06

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

1.0

—

0.01

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.21

0.0

1.0

—

5.12

—

Type 1 diabetes, definitions combined

0.00

0.21

0.0

1.0

—

5.12

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.21

0.0

1.0

—

5.15

—

Umbilical hernia

0.00

0.21

0.0

1.0

—

0.17

—

Dementia, including avohilmo

0.00

0.20

0.0

1.0

—

0.02

—

Any event in cancer register

1.25

0.20

1.0

0.05

1.44

u/ml

—

Poor fetal growth

0.00

0.20

0.0

1.0

—

5.91

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.20

0.0

1.0

—

5.95

—

Autoimmune diseases

1.19

0.19

1.0

0.59

1.22

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.18

0.15

1.0

4.31

0.35

u/ml

—

Intestinal infectious diseases

1.17

0.13

1.0

4.23

0.51

u/ml

—

Used for control exclusion in common control thyroid runs

1.12

0.09

1.0

0.25

1.26

u/ml

—

Benign neoplasms

0.89

0.07

1.0

6.11

0.52

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

1.10

0.06

1.0

4.28

0.39

u/ml

—

Other diseases of intestines

1.09

0.05

1.0

0.28

1.16

u/ml

—

Any gastric operation

1.09

0.04

1.0

5.07

0.35

u/ml

—

GASTRO-related operations

1.09

0.04

1.0

5.07

0.35

u/ml

—

Autoimmune diseases excluding thyroid diseases

0.95

0.00

1.0

0.21

1.25

u/ml

—

Gingivitis and periodontal diseases

1.03

0.00

1.0

5.04

0.29

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.99

0.00

1.0

0.11

1.09

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.97

0.00

1.0

0.21

1.25

u/ml

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carrot IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS